BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17626310)

  • 1. Prophylactic radiotherapy for glioblastoma in the elderly.
    Tartarone A; Ardito R; Romano C
    N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
    [No Abstract]   [Full Text] [Related]  

  • 2. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of brain tumors.
    Ashby L; LaRocca R; Ryken T
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of brain tumors.
    Seiter K
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938012
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005).
    Jalali R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1622; author reply 1622-3. PubMed ID: 19028293
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for brain tumors--a new beginning.
    DeAngelis LM
    N Engl J Med; 2005 Mar; 352(10):1036-8. PubMed ID: 15758016
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation as a foundation for glioblastoma therapy in elderly patients. In Regard to Arvold et al.
    Giaj Levra N; Fiorentino A; Fersino S; Ricchetti F; Mazzola R; Alongi F
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):217-8. PubMed ID: 26279046
    [No Abstract]   [Full Text] [Related]  

  • 9. Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.
    Roa W; Xing JZ; Small C; Kortmann R; Miriamanoff R; Okunieff P; Shibamoto Y; Jeremic B
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1643-50. PubMed ID: 19895247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant temozolomide: how long and how much?
    Franceschi E; Tosoni A; Brandes AA
    Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
    [No Abstract]   [Full Text] [Related]  

  • 12. Temozolomide in glioblastoma multiforme of the elderly.
    Brandes AA; Vastola F; Basso U; Pasetto LM; Ermani M; Berti F; Rotilio A; Amistà P; Scienza R; Monfardini S
    Tumori; 2002; 88(1 Suppl 1):S69-70. PubMed ID: 11989929
    [No Abstract]   [Full Text] [Related]  

  • 13. Going past the data for temozolomide.
    Villano JL; Letarte N; Bressler LR
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status quo--standard-of-care medical and radiation therapy for glioblastoma.
    Becker KP; Yu J
    Cancer J; 2012; 18(1):12-9. PubMed ID: 22290252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
    Linz U
    Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In reply to Gondi and Mehta.
    Huang J; Robinson CG; Badiyan SN
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):454-5. PubMed ID: 25636773
    [No Abstract]   [Full Text] [Related]  

  • 17. MSH6 inactivation and emergent temozolomide resistance in human glioblastomas.
    Cahill DP; Codd PJ; Batchelor TT; Curry WT; Louis DN
    Clin Neurosurg; 2008; 55():165-71. PubMed ID: 19248684
    [No Abstract]   [Full Text] [Related]  

  • 18. In Regard to Arvold et al.
    Fiorica F; Colella M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):939. PubMed ID: 26530769
    [No Abstract]   [Full Text] [Related]  

  • 19. In Reply to Levra et al.
    Arvold ND; Tanguturi SK; Alexander BM
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):218-9. PubMed ID: 26279047
    [No Abstract]   [Full Text] [Related]  

  • 20. The evolution of chemoradiation for glioblastoma: a modern success story.
    Mirimanoff RO
    Curr Oncol Rep; 2006 Jan; 8(1):50-3. PubMed ID: 16464403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.